Vaxcyte, Inc. (PCVX) NASDAQ
47.76
+0.37(+0.78%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
47.76
+0.37(+0.78%)
Currency In USD
| Market Cap | 6.28B |
| Enterprise Value | 6.33B |
| P/E Ratio | -7.04 |
| PEG Ratio | 0.15 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.22 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -7.14 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.28 |
| Return On Equity | -0.33 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -741.77M |
| Net Income | -766.63M |
| Diluted EPS | -5.63 |
| Total Cash | 1.74B |
| Total Cash/Share | 12.45 |
| Total Debt | 116.3M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 7.49 |
| Book Value Per Share | 21.48 |
| 52-Week Change | 40.68 |
| 52-Week High | 65 |
| 52-Week Low | 29.08 |
| Moving Average 50 Days | 56.62 |
| Moving Average 200 Days | 47.39 |
| Average Volume | 1.69M |
| Shares Outstanding | 144.4M |
| % Held by Institutions | 119.43 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |